DOI: 10.1128/AAC.00082-07
Article Information
PubMed
Published By
History
- Received January 19, 2007
- Returned for modification March 7, 2007
- Accepted June 7, 2007
- Published online August 22, 2007.
Copyright & Usage
Copyright © 2007 American Society for Microbiology
Article Versions
- Accepted Manuscript version (June 18, 2007).
- You are viewing the most recent version of this article.
Author Information
- Xianbin Tian1†,
- Jun Li1,
- Maciej J. Zamek-Gliszczynski1‡,
- Arlene S. Bridges1,
- Peijin Zhang1§,
- Nita J. Patel2,
- Thomas J. Raub2,
- Gary M. Pollack1 and
- Kim L. R. Brouwer1*
- 1School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina
- 2Eli Lilly and Company, Drug Disposition, Indianapolis, Indiana
- ↵* Corresponding author. Mailing address: Division of Pharmacotherapy and Experimental Therapeutics, School of Pharmacy, C.B. 7360, Kerr Hall, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7360. Phone: (919) 962-7030. Fax: (919) 962-0644. E-mail: kbrouwer{at}unc.edu
↵† Present address: Wyeth, Discovery Pharmacokinetics, Andover, MA.; ‡ Present address: Eli Lilly and Company, Drug Disposition, Indianapolis, IN.; § Present address: MPI Research, Mattawan, MI.
▿ Published ahead of print on 18 June 2007.
